For a better experience of our website please update you web browser from IE11 to Microsoft Edge or an alternative modern browser such as Google Chrome. Thank you.

Your partner in science for end-to-end CRDMO solutions

In vitro Biology & Pharmacology Solutions

The In vitro Biology Group has the expertise to perform a variety of biochemical and cellular assays against varied target classes, including enzymes, GPCR’s, NHR’s and transporters.

The department is equipped with necessary infrastructure and updated technologies for in vitro pharmacology services to enable these assays, including sophisticated liquid-handling, compound-handling and assay-detection systems.

With a high ratio of PhD scientists with global exposure and long-standing discovery experience, Jubilant Biosys is well-placed to support target validation, assay development, screening and mechanism of action for first-in-class & best-in-class requirements.

The following functional services are provided:

  • Biochemical based assay development, validation & screening
  • Biophysical assay development, validation & screening
  • Cell-based assay development, validation & screening
  • Immune-cell based development, validation & screening

Assay Technologies

  • Fluorescence – FP, TR-FRET, HTRF, Lance
  • Luminescence, absorbance, alpha technology
  • Meso Scale Discovery [MSD], Intelliflex [Luminex Platform]
  • LYCOR, Traditional Western, Simple WES
  • FLIPR Penta
  • Radiometric – SPA, Filter Binding, Flash Plate
  • Label free approaches

Our experienced team of in vitro pharmacology brings strong problem-solving skills and expertise in a large variety of assays involving platforms mentioned above.

Biology Assay Development & Validation

We offer extensive  assay development and validation service required in the discovery process. Our biologists assist you with precise and adaptable assays to screen small molecules and support discovery from hit-to-lead, to preclinical candidate (PCC) declaration.

Jubilant Biosys has expertise in various therapeutic areas, including oncology, CNS, metabolic disorders, pain & inflammation.

We have delivered on novel requirements and supported over 85 IDD programs successfully, working with DNA, protein & RNA target classes and worked with leading Biotech & Pharma companies.